For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 0 | 0 | 59,824 | 107,135 |
| Cost of sales | 0 | 0 | 31,075 | 51,727 |
| Gross profit | 0 | 0 | 28,749 | 55,408 |
| Selling, general and administrative expenses | 9,939 | 2,656 | 22,705 | 26,316 |
| (loss) income from operations | -9,939 | -2,656 | 6,044 | 29,092 |
| Revaluation of warrant liability | 117,267 | 53,436 | -17,921 | 74,418 |
| Interest expense, net | - | - | - | -5,136 |
| Revaluation of earnout consideration liability | -57,610 | -10,721 | 11,230 | -34,530 |
| Change in fair value of derivative liability - convertible notes redemption make-whole provision | 0 | 0 | - | 544 |
| Interest expense | 0 | 0 | 1,688 | - |
| Interest income | 287 | 17 | 219 | - |
| Loss on extinguishment of debt | 0 | - | - | -148 |
| Amortization of deferred financing costs | 0 | 0 | 74 | 249 |
| Total other expense, net | -174,590 | -64,140 | 27,608 | -113,937 |
| Loss before income taxes | -184,529 | -66,796 | 33,652 | -84,845 |
| Income tax expense | 29,804 | -1,762 | 27,004 | 629 |
| Loss before earnings in equity method investment | -214,333 | -65,034 | 6,648 | - |
| Earnings in equity method investment | 39,637 | 38,909 | 14,844 | - |
| Net loss | -174,696 | -26,125 | 21,492 | -85,474 |
| Net loss attributable to redeemable non-controlling interests | 0 | 0 | - | -43,414 |
| Net loss attributable to composecure, inc | -174,696 | -26,125 | 21,492 | -42,060 |
| Basic EPS | -1.58 | -0.26 | 0.21 | -1.1 |
| Diluted EPS | -1.58 | -0.26 | 0.07 | -1.1 |
| Basic Average Shares | 110,265,000 | 102,321,754 | 102,040,000 | 38,212,000 |
| Diluted Average Shares | 110,265,000 | 102,321,754 | 113,270,000 | 38,212,000 |
CompoSecure, Inc. (CMPO)
CompoSecure, Inc. (CMPO)